These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12457003)

  • 1. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test.
    Ferrari M; Segattini C; Zanon R; Bertaiola M; Balestreri F; Brotto E; Lo Cascio V
    Respiration; 2002; 69(6):509-12. PubMed ID: 12457003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma.
    Ferrari M; Balestreri F; Baratieri S; Biasin C; Oldani V; Lo Cascio V
    Respiration; 2000; 67(5):510-3. PubMed ID: 11070454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
    Shapiro GS; Yegen U; Xiang J; Kottakis J; Della Cioppa G
    Clin Ther; 2002 Dec; 24(12):2077-87. PubMed ID: 12581546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
    Richter K; Janicki S; Jörres RA; Magnussen H
    Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.
    Bronsky EA; Pearlman DS; Pobiner BF; Scott C; Wang Y; Stahl E
    Pediatrics; 1999 Sep; 104(3 Pt 1):501-6. PubMed ID: 10469776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ; Dempsey OJ; Aziz I
    Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formoterol provides long-lasting protection against exercise-induced bronchospasm.
    Bronsky EA; Yegen U; Yeh CM; Larsen LV; Della Cioppa G
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):407-12. PubMed ID: 12392386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of protection by inhaled salmeterol in exercise-induced asthma.
    Anderson SD; Rodwell LT; Du Toit J; Young IH
    Chest; 1991 Nov; 100(5):1254-60. PubMed ID: 1682113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children.
    Pearlman D; Milgrom H; Till D; Ziehmer B
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):382-8. PubMed ID: 17042146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
    Condemi JJ
    Clin Ther; 2001 Sep; 23(9):1529-41. PubMed ID: 11589265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action.
    van Noord JA; Smeets JJ; Raaijmakers JA; Bommer AM; Maesen FP
    Eur Respir J; 1996 Aug; 9(8):1684-8. PubMed ID: 8866595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
    Kemp JP; Dockhorn RJ; Busse WW; Bleecker ER; Van As A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1612-5. PubMed ID: 7952623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
    Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
    Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of measured and perceived bronchodilation. A placebo-controlled cross-over trial comparing formoterol and salmeterol in moderate persistent asthma.
    Schermer TR; Hoff WJ; Greefhorst AP; Creemers JP; Sips AP; Westbroek J; van Herwaarden CL
    Pulm Pharmacol Ther; 2004; 17(4):205-12. PubMed ID: 15219265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
    Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA
    Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
    Celik G; Kayacan O; Beder S; Durmaz G
    Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.